Brain parenchymal and microvascular amyloid in Alzheimer's disease

Brain Pathology

Volumn 6, Issue 2, 1996, Pages 179-195

  Vinters, Harry V ^a   Wang, Zhen Zhen ^a   Secor, Diana Lenard ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; AUTOPSY; BRAIN BIOPSY; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; REVIEW;

EID: 0029975660     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00799.x     Document Type: Review

References (169)

1. Anders KH, Secor DL, Vinters HV (1993) Cerebral amyloid angiopathy (CAA) associated with ischemic necrosis. J Neuropathol Exp Neurol 52: 275 [abstract]
2. Arai H, Sagi N, Noguchi I, Haga S, Ishii T, Makino Y, Kosaka K (1989) An immunohistochemical study of beta-protein in Alzheimer-type dementia brains. J Neurol 236: 214-217
3. Bahmanyar S, Higgins GA, Geldgeber D, Lewis DA, Morrison JH, Wilson MC, Shankar SK, Gajdusek DC (1987) Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science 237: 77-80
4. Bell MA, Ball MJ (1990) Neuritic plaques and vessels of visual cortex in aging and Alzheimer's dementia. Neurobiol Aging 11: 359-370
5. Bergeron C, Ranalli PJ, Miceli PN (1987) Amyloid angiopathy in Alzheimer's disease Can J Neurol Sci 14: 564-569
6. Bird TD, Sumi SM, Nemens EJ, Nochlin D, Schellenberg G, Lampe TH, Sadovnick A, Chui H, Miner GW, Tinklenberg J (1989) Phenotypic heterogeneity in familial Alzheimer's disease: A study of 24 kindreds. Ann Neurol 25: 12-25
7. Blumenthal HT, Premachandra BN (1990) The aging-disease dichotomy. Cerebral amyloid angiopathy - an independent entity associated with dementia. J Am Geriatr Soc 38: 475-482
8. Braak H, Braak E (1990) Alzheimer's disease: Striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 49: 215-224
9. Braak H, Braak E (1990) Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol 80: 479-486
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
11. Braak H, Braak E, Bohl J, Lang W (1989) Alzheimer's disease, amyloid plaques in the cerebellum. J Neurol Sci 93 277-287
12. Briceno CE, Resch L, Bernstein M (1987) Cerebral amyloid angiopathy presenting as a mass lesion. Stroke 18: 234-239
13. Castano EM, Frangione B (1988) Human amyloidosis, Alzheimer disease and related disorders. Lab Invest 58: 122-132
14. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360: 672-674
15. Claudio L (1996) Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol 91:6-14
16. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
17. Corsellis JAN, Brierley JB (1954) An unusual type of presenile dementia (Atypical Alzheimer's disease with amyloid vascular change). Brain 77: 571-587
18. Cork LC, Masters C, Beyreuther K, Price DL (1990) Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am J Pathol 137: 1383-1392
19. Crooks DA (1994) Cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 57: 1457
20. Davis-Salinas J, Van Nostrand WE (1995) Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem 270: 20887-20890
21. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ (1991) Subtypes and differential laminar distributions of betaA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81: 328-335
22. Dewji NN, Singer SJ (1996) Genetic clues to Alzheimer's disease. Science 271: 159-160
23. Divry P (1927) Etude histo-chimique des plaques seniles. J de Neurologie et de Psychiatrie 27: 643-657
24. Duff K, Hardy J (1995) Mouse model made. Nature 373: 476-477
25. Emre M, Geula C, Ransil BJ, Mesulam M-M (1992) The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain. Neurobiol Aging 13: 553-559
26. Engel PA, Vinters HV, Grunnet M (1992) Alzheimer's disease or plaque disease? Two cases at the frontier of a definition. J Geriatr Psychiatry Neurol 5: 200-209
27. Farlow M, Murrell J, Ghetti B, Unverzagt F, Zeldenhurst S, Benson M (1994) Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a GT change at position 2149 of the amyloid precursor protein gene. Neurology 44: 105-111
28. Fountain NB, Eberhard DA (1996) Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: Report of two cases and review of the literature. Neurology 46: 190-197
29. Frackowiak J, Mazur-Kolecka B, Wisniewski HM, Potempska A, Carroll RT, Emmerling MR, Kim KS (1995) Secretion and accumulation of Alzheimer's beta-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Research 676: 225-230
30. Frackowiak J, Zoltowska A, Wisniewski HM (1994) Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 53, 637-645
31. Frautschy SA, Cole GM, Baird A (1992) Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol 140: 1389-1399
32. Frucht SJ, Koo EH (1993) Beta-amyloid protein is higher in Alzheimer's disease brains: Description of a quantitative biochemical assay. J Neuropathol Exp Neurol 52: 640-647
33. Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T (1996) Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Am J Pathol 148: 259-265
34. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S,Masliah E. McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523-527
35. Gentleman SM, Allsop D, Bruton CJ, Jagoe R, Polak JM, Roberts GW (1992) Quantitative differences in the deposition of betaA4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease. Neurosci Lett 136 27-30
36. Ghetti B, Murrell J, Benson MD, Farlow MR (1992) Spectrum of amyloid beta-protein immunoreactivity in hereditary Alzheimer disease with a guanine to thymine missense change at position 1924 of the APP gene. Brain Research 571: 133-139
37. Giaccone G, Pedrotti B, Migheli A, Verga L, Perez J, Racagni G, Smith MA, Perry G, De Gioia L, Selvaggini C, Salmona M, Ghiso J, Frangione B, Islam K, Bugiani O, Tagliavini F (1996) BetaPP and tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. Am J Pathol 148. 79-87
38. Glenner GG (1983) Alzheimer's disease. The commonest form of amyloidosis. Arch Pathol Lab Med 107: 281-282
39. Glenner GG (1985) On causative theories in Alzheimer's disease. Hum Pathol 16: 433-435
40. Glenner GG, Henry JH, Fujihara S (1981) Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1: 120-129
41. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890
42. Glenner GG, Wong CW (1984) Alzheimer's disease and Down's syndrome sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commmun 122: 1131-1135
43. Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of beta amyloid protein precursor mRNAs' Recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4: 253-267
44. Gray F, Dubas F, Roullet E, Escourolle R (1985) Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy Ann Neurol 18: 54-59
45. Gray F, Vinters HV, Le Noan H, Salama J, Delaporte P, Poirier J (1990) Cerebral amyloid angiopathy and granulomatous angiitis: Immunohistochemical study using antibodies to the Alzheimer A4 peptide. Hum Pathol 21: 1290-1293
46. Greenberg SM, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT (1995) Apolipoprotein E epsilon4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38: 254-259
47. Greenberg SM, Vonsattel JPG, Stakes JW, Gruber M, Finklestein SP (1993) The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage. Neurology 43: 2073-2079
48. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325
49. Haass C, Selkoe DJ (1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75: 1039-1042
50. Ikeda S, Allsop D, Glenner GG (1989) Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases An immunohistochemical study using amyloid beta-protein antibody. Lab Invest 60: 113-122
51. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y (1995) Amyloid beta protein (Abeta) deposition: Abeta42(43) precedes Abeta40 in Down's syndrome. Ann Neurol 37: 294-299
52. Joachim C, Games D, Morris J, Ward P, Frenkel D, Selkoe D (1991) Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques. Am J Pathol 138: 373-384
53. Joachim CL, Mori H, Selkoe DJ (1989) Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341: 226-230
54. Joachim CL, Morris JH, Selkoe DJ (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 135: 309-319
55. Joachim CL, Selkoe DJ (1992) The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disorders 6: 7-34
56. Kalaria RN (1992) The blood-brain barrier and cerebral microcirculation in Alzheimer disease Cerebrovasc Brain Metabolism Reviews 4: 226-260
57. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Research 623: 142-146
58. Kawai M, Kalaria RN, Hank SI, Perry G (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 137: 1435-1446
59. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
60. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57: 230-236
61. Kosik KS (1992) Alzheimer's disease: A cell biological perspective. Science 256: 780-783
62. Kowall NW, McKee AC, Yankner BA, Beal MF (1992) In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment Neurobiol Aging 13: 537-542
63. Krucke W (1952) Die amyloidose der gehirngefasse. Proc First Int'l Congress of Neuropathology, Rome, Italy, 2: 237-248
64. Kurucz J, Charbonneau R, Kurucz A, Ramsey P (1981) Quantitative clinicopathologic study of cerebral amyloid angiopathy. J Am Geriatr Soc 29. 61-69
65. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's Abeta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics 9: 21-29
66. Lamb BT (1995) Making models for Alzheimer's disease. Nature Genetics 9: 4-6
67. Mak K, Yang F, Vinters HV, Frautschy SA, Cole GM (1994) Polyclonals to beta-amyloid (1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum Brain Research 667: 138-142
68. Malouf AT (1992) Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging 13 543-551
69. Mandybur TI (1975) The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 25. 120-126
70. Mandybur TI (1986) Cerebral amyloid angiopathy: The vascular pathology and complications J Neuropathol Exp Neurol 45: 79-90
71. Mann DMA (1989) Cerebral amyloidosis, ageing and Alzheimer's disease; A contribution from studies on Down's syndrome. Neurobiol Aging 10: 397-399
72. Mann DMA, Esiri MM (1989) The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 89: 169-179
73. Mann DMA, Jones D, Prinja D, Purkiss MS (1990) The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol 80: 318-327
74. Marotta CA, Majocha RE, Tate B (1992) Molecular and cellular biology of Alzheimer amyloid. J Mol Neurosci 3: 111-125
75. Marx J (1992) Alzheimer's debate boils over Science 257: 1336-1338
76. Masliah E, Terry RD, Mallory M, Alford M, Hansen LA (1990) Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 137: 1293-1297
77. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245-4249
78. Mattiace LA, Davies P, Yen S-H, Dickson DW (1990) Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropathol 80:493-498
79. McMenemey WH (1940) Alzheimer's disease. A report of six cases. J Neurol Psychiat 3: 211-240
80. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JR van Belle G, Berg L, and participating CERAD neuropathologists (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
81. Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y (1982) The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch [Cell Pathol] 40: 121-129
82. Miyakawa T, Uehara Y (1979) Observations of amyloid angiopathy and senile plaques by the scanning electron microscope. Acta Neuropathol 48: 153-156
83. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 38: 643-648
84. Murphy M (1992) The molecular pathogenesis of Alzheimer's disease: clinical prospects. Lancet 340: 1512-1515
85. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254: 97-99
86. Nadeau SE, Bebin J. Smith E (1987) Nonspecific dementia, cortical blindness, and Congophilic angiopathy A clinicopathological report. J Neurol '234: 14-18
87. Nakamura T, Shoji M, Harigaya Y, Watanabe M, Hosoda K, Cheung TT, Shaffer LM, Golde TE, Younkin LH, Younkin SG, Hirai S (1994) Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann Neurol 36: 903-911
88. Neumann MA (1960) Combined amyloid vascular changes and argyrophilic plaques in the central nervous system. J Neuropathol Exp Neurol 19: 370-382
89. Neve RL, Finch EA, Dawes LR (1988) Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1: 669-677
90. Nicoll JAR, Burnett C, Love S, Graham DI, Ironside JW, Vinters HV (1996) High frequency of apolipoprotein E epsilon2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (in press)
91. Ohgami T, Kitamoto T, Shin R-W, Kaneko Y, Ogomori K, Tateishi J (1991) Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathol 81: 242-247
92. Ohshima T, Endo T, Nukui H, Ikeda S, Allsop D, Onaya T (1990) Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage Stroke 21: 480-483
93. Oltersdorf T, Fritz LC, Schenk DB, Lieberburg I, Johnson-Wood KL, Beattie EC, Ward PJ, Blacher RW, Dovey HF, Sinha S (1989) The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 341: 144-147
94. Palmert MR, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Usiak MF, Younkin LH, Younkin SG (1988) Amyloid protein precursor messenger RNAs: Differential expression in Alzheimer's disease. Science 241: 1080-1084
95. Pantelakis S (1954) Un type particulier d'angiopathie senile du systeme nerveux central: l'angiopathie congophile. Topographie et frequence. Mschr Psychiat Neurol 128: 219-256
96. Pappolla MA, Omar RA, Vinters HV (1991) Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques. Am J Pathol 139: 599-607
97. Pardridge WM, Buciak JL, Yang J, Miller BL, Vinters HV (1991) Measurement of amyloid peptide precursor of Alzheimer disease in human blood by double antibody immunoradiometric assay. Alzheimer Dis Assoc Disorders 5: 12-24
98. Pardridge WM, Vinters HV, Yang J, Eisenberg J, Choi TB, Tourtellotte WW, Huebner V, Shively JE (1987) Amyloid angiopathy of Alzheimer's disease: Amino acid composition and partial sequence of a 4,200-Dalton peptide isolated from cortical microvessels. J Neurochem 49: 1394-1401
99. Podlisny MB, Mammen AL, Schlossmacher MG, Palmert MR, Younkin SG, Selkoe DJ (1990) Detection of soluble forms of the beta-amyloid precursor protein in human plasma. Biochem Biophys Res Commun 167: 1094-1101
100. Podlisny MB, Stephenson DT, Frosch MP, Lieberburg I, Clemens JA, Selkoe DJ (1992) Synthetic amyloid beta-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol Aging 13: 561-567
101. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699
102. Prelli F, Castano E, Glenner GG, Frangione B (1988) Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 51. 648-651
103. Price DL, Sisodia SS, Gandy SE (1995) Amyloid beta amyloidosis in Alzheimer's disease. Current Opinion in Neurology 8: 268-274
104. Pro JD, Smith CH, Sumi SM (1980) Presenile Alzheimer disease: Amyloid plaques in the cerebellum. Neurology 30: 820-825
105. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 37: 211-217
106. Roberts GW, Lofthouse R, Allsop D, Landon M, Kidd M, Prusiner SB, Crow TJ (1988) CNS amyloid proteins in neurodegenerative diseases. Neurology 38: 1534-1540
107. Roher A, Wolfe D, Palutke M, KuKuruga D (1986) Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 83: 2662-2666
108. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Cowing E, Ball MJ (1993) Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90: 10836-10840
109. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53: 429-437
110. 1-40/vector complex. Proc Natl Acad Sci USA 92: 10227-10231
111. Saitoh T, Sundamo M, Roch J-M, Kimura N, Cole G, Schubert D, Oltersdorf T, Schenk DB (1989) Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts Cell 58: 615-622
112. Schellenberg GD (1995) Progress in Alzheimer's disease genetics. Current Opinion in Neurology 8: 262-267
113. Schmechel DE, Goldgaber D, Burkhart DS, Gilbert JR, Gajdusek DC, Roses AD (1988) Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease. Alzheimer Dis Assoc Disorders 2: 96-111
114. Scott J (1993) Apolipoprotein E and Alzheimer's disease. Lancet 342: 696
115. Selkoe DJ (1989) Biochemistry of altered brain proteins in Alzheimer's disease. Ann Rev Neurosci 12: 493-520
116. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498
117. Selkoe DJ (1994) Alzheimer's disease: A central role for amyloid. J Neuropathol Exp Neurol 53: 438-447
118. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC (1987) Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235: 873-877
119. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359: 325-327
120. Shimode K, Fujihara S, Nakamura M, Kobayashi S, Tsunematsu T (1991) Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cerebrospinal fluid. Stroke 22 860-866
121. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y (1995) Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 38 421-428
122. Silbert PL, Bartleson JD, Miller GM, Parisi JE, Goldman MS, Meyer FB (1995) Cortical petechial hemorrhage, leukoencephalopathy, and subacute dementia associated with seizures due to cerebral amyloid angiopathy Mayo Clin Proc 70: 477-480
123. Sinha S, Lieberburg I (1992) Normal metabolism of the amyloid precursor protein (APP). Neurodegeneration 1: 169-175
124. Sisodia SS (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 89: 6075-6079
125. Smith C, Anderton BH (1994) The molecular pathology of Alzheimer's disease: are we any closer to understanding the neurodegenerative process? Neuropathol Appl Neurobiol 20. 322-338
126. Smith DB, Hitchcock M, Philpott PJ (1985) Cerebral amyloid angiopathy presenting as transient ischemic attacks. Case report. J Neurosurg 63: 963-964
127. Snow AD, Malouf AT (1993) In vitro and in vivo models to unravel the potential roles of beta/A4 in the pathogenesis of Alzheimer's disease Hippocampus 3: 257-268
128. Snow AD, Mar H, Nochlin D, Kresse H, Wight TN (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J Histochem Cytochem 40: 105-113
129. Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight TN (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137. 1253-1270
130. Soininen H, Syrjanen S, Heinonen O, Neittaanmaki H, Miettinen R, Paljarvi L, Syrjanen K, Beyreuther K, Riekkinen P (1992) Amyloid beta-protein deposition in skin of patients with dementia. Lancet 339: 245
131. Stewart PA, Hayakawa K, Akers M-A, Vinters HV (1992) A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 67: 734-742
132. Suenaga T, Hirano A, Llena JF, Ksiezak-Reding H, Yen S-H, Dickson DW (1990) Modified Bielschowsky and immunocytochemical studies on cerebellar plaques in Alzheimer's disease. J Neuropathol Exp Neurol 49: 31-40
133. Surbek B (1961) L'angiopathie dyshorique (Morel) de l'ecorce cerebrale. Etude anatomo-clinique et statistique, aspect genetique. Acta Neuropathol 1. 168-197
134. Tabaton M, Mandybur TI, Perry G, Onorato M, Autilio-Gambetti L, Gambetti P (1989) The widespread alteration of neuntes in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol 26: 771-778
135. Tanzi RE (1995) A promising animal model of Alzheimer's disease. N Engl J Med 332: 1512-1513
136. Tokuda T, Ikeda S, Maruyama K, Yanagisawa N, Ito N (1992) Spinal cord vascular and leptomeningeal amyloid beta-protein deposition in a case with cerebral amyloid angiopathy. Acta Neuropathol 34: 207-210
137. Tomlinson BE, Blessed G, Roth M (1968) Observations on the brains of non-demented old people J Neurol Sci 7: 331-356
138. Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205-242
139. van Gool WA, Kuiper MA, Walstra GJM, Wolters ECh, Bolhuis PA (1995) Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease Ann Neurol 37. 277-279
140. Van Nostrand WE, Wagner SL, Shankle WR, Farrow JS, Dick M, Rozemuller JM, Kuiper MA, Wolters EC, Zimmerman J, Cotman CW, Cunningham DD (1992) Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci USA 89: 2551-2555
141. Van Nostrand WE, Wagner SL, Suzuki M, Choi BH, Farrow JS, Geddes JW, Cotman CW, Cunningham DD (1989) Protease nexin-ll, a potent anti-chymotrypsin, shows identity to amyloid beta-protein precursor. Nature 341: 546-549
142. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB (1993) Characterization of beta-amyloid peptide from human cerebrospinal fluid. J Neurochem 61: 1965-1968
143. Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18. 311-324
144. Vinters HV (1990) Amyloid and the central nervous sys-tem: The neurobiology, genetics and immunocytochemistry of a process important in neurodegenerative diseases and stroke. In: Neuropathology (U.S. & Canadian Academy of Pathology Inc. Monograph Series), PA Cancilla, FS Vogel, N Kaufman (eds.), pp. 55-85, Baltimore-Hong Kong-London-Sydney. Williams & Wilkins
145. Vinters HV (1992) Cerebral amyloid angiopathy and Alzheimer's disease: two entities or one? J Neurol Sci 112: 1-3
146. Vinters HV (1992) Cerebral amyloid angiopathy. In: Stroke. Pathophysiology, Diagnosis, and Management, 2nd Edition, HJM Barnett, JP, Mohr, BM Stein, FM Yatsu (eds.), pp. 821-858, New York-Edinburgh-London:Churchill Livingstone
147. Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: Incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14: 924-928
148. Vinters HV, Miller BL, Pardridge WM (1988) Brain amyloid and Alzheimer disease. Ann Intern Med 109: 41-54
149. Vinters HV, Nishimura GS, Secor DL, Pardridge WM (1990) Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am Pathol 137: 233-240
150. Vinters HV, Pardridge WM, Secor DL, Ishii N (1988) Immunohistochemical study of cerebral amyloid angiopathy. II Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am J Pathol 133: 150-162
151. Vinters HV, Pardridge WM, Yang J (1988) Immunohistochemical study of cerebral amyloid angiopathy: Use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. Hum Pathol 19: 214-222
152. Vinters HV, Secor DL, Pardridge WM, Gray F (1990) Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol 28: 34-42
153. Vinters HV, Secor DL, Read SL, Frazee JG, Tomiyasu U, Stanley TM, Ferreiro JA, Akers M-A (1994) Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructural study Ultrastruct Pathol 18: 333-348
154. Vonsattel JPG, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages A comparative histological study. Ann Neurol 30: 637-649
155. Walker LC, Masters C, Beyreuther K, Price DL (1990) Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol 80: 381-387
156. Walker LC, Price DL, Voytko ML, Schenk DB (1994) Labeling of cerebral amyloid in vivo with a monoclonal antibody. J Neuropathol Exp Neurol 53: 377-383
157. Whitson JS, Selkoe DJ, Cotman CW (1989) Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science 243: 1488-1490
158. Wisniewski HM, Bancher C, Barcikowska M, Wen GY, Currie J (1989) Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol 78: 337-347
159. Wisniewski HM, Frackowiak J, Mazur-Kolecka B (1995) In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett 183: 120-123
160. Wisniewski HM, Frackowiak J, Zoltowska A, Kim KS (1994) Vascular beta-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid: Int't J Exp Clin Invest 1: 8-16
161. Wisniewski HM, Rabe A, Zigman W, Silverman W (1989) Neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 48: 606-609
162. Wisniewski HM, Weigel J (1993) Migration of perivascular cells into the neuropil and their involvement in beta-amyloid plaque formation. Acta Neuropathol 85: 586-595
163. Wisniewski HM, Wen GY, Kim KS (1989) Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol 78: 22-27
164. Wong CW, Quaranta V, Glenner GG (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related Proc Natl Acad Sci USA 82: 8729-8732
165. Worster-Drought C, Greenfield JG, McMenemey WH (1944) A form of familial presenile dementia with spastic paralysis. Brain 67: 38-43
166. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ (1992) Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. Am J Pathol 141: 249-259
167. Yang F, Mak K, Vinters HV, Frautschy SA, Cole GM (1994) Monoclonal antibody to the C-terminus of beta-amyloid. NeuroReport 5: 2117-2120
168. Yong WH, Robert ME, Secor DL, Kleikamp TJ, Vinters HV (1992) Cerebral hemorrhage with biopsy-proved amyloid angiopathy Arch Neurol 49: 51-58
169. Younkin SG (1995) Evidence that Abeta42 is the real culprit in Alzheimer's disease. Ann Neurol 37: 287-288